Abstract CT180: Safety and efficacy of vibostolimab (vibo) plus pembrolizumab (pembro) and coformulation of vibo/pembro in ovarian cancer naive to PD-1/PD-L1 inhibitors

Authors: Ruth Perets, Martin Gutierrez, Sun Young Rha, Sarah Taylor, Brian Stein, Antonio Jimeno, Ira Winer, Diana Chen, Tanya Keenan, Mohini Rajasagi, Mallika Lala, Jane Healy, Ronnie Shapira-Frommer

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-ct180

Source: Full article